TRI (Thomson Reuters C)
All Pro Portfolios with TRI

People owning TRI also tend to own:: DISEGNGEMOAAPLBCSBNS

All Do-It-Yourself Portfolios with TRI
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:High Dividends

Date:05 06 09

39.2

Not yet rated
Rate now:

By:High Dividends

Date:04 08 09

52.4

Not yet rated
Rate now:

By:High Dividends

Date:02 12 09

PE ratio: na Short ratio: 46.1

Not yet rated
Rate now:

By:High Dividends

Date:01 09 09

negative earnings, short ratio of 40

Not yet rated
Rate now:

By:High Dividends

Date:12 17 08

34.6

Not yet rated
Rate now:

By:High Dividends

Date:11 13 08

23.3

Not yet rated
Rate now:

By:stockerblog

Date:11 06 08

11/19/2008

Not yet rated
Rate now:

By:High Dividends

Date:10 15 08

57.1

Not yet rated
Rate now:

By:stockerblog

Date:08 06 08

8/19/2008

Not yet rated
Rate now:

By:sarah z

Date:06 19 08

The New York Based provider of financial information said it will buyback $500 million in common stock. Under the buyback, as many as 15 million shares may be repurchased, representing 1.81% of the total outstanding shares. The company said it will start repurchasing the shares on June 6, 2008 and will terminate by June 5, 2009.

On May 1, 2008 the company announced impressive first quarter results with revenue surging 12% to $3.25 billion. On April 17, 2008 the company completed the purchase of Reuters which it began 11 months ago. As part of the purchase, they will reduce costs sooner than anticipated. They said annualized savings will be $1 billion by the end of 2010 and $1.2 billion in 2011. The company added that it expects to grow 8% this year.

“Our combined first quarter results and guidance for the full year reflect the robustness of our business, even in turbulent markets. Our Markets Division holds leading positions in higher growth segments of the financial markets, including foreign exchange, commodities, energy and emerging markets.” said Thomas H. Glocer, CEO of Thomson Reuters. “These are high quality businesses with attractive profit margins and strong cash flow characteristics.”

Analyst Vince Valentini with TD Newcrest equity research has a buy rating and a $53 price target on the stock. He said, “We continue to believe that the best way to value TRI shares is to look forward to 2010 or 2011 results when the net impact from synergies and integration costs becomes more normalized.”

Not yet rated
Rate now:

Why I Hate This Stock

By:cntrybleu

Date:02 09 07

They sold out from what I hear, there may be a turn, but I just dont see anything in the future for right now.

Not yet rated
Rate now:
Add Your Comments  
Stock TRI
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
Stockpickr's Picks of the Day: J...

By Rebecca Corvino Posted on July 2, 2009 Every day, Stockpickr members are creating and sharing stock ideas with each other through various platforms. If you're not al...

07.02.09 | 13:43 PM
Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:30 p.m. EDT on July 2, 2009 Making Thursday's headlines and sending stocks lower were reports that June saw the loss of 467,000 more job...

07.02.09 | 12:31 PM
Dividend Stocks for the Week

By Stockpickr Staff Posted on July 2, 2009 Some investors assume that at this time of year, it's the summer doldrums for the stock market. After all, as the saying goe...

07.02.09 | 11:02 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
what happened to DSCO?
07.02.09 | 11:45 AM From author Disco Duck
more forums
Q. hgsi lupus drug. results on jul...
07.03.09 | 23:42 PM Asked by 1surfer2

A. the data seems really positive ... I
just read through BioMedReports and
thought it was impressive - the largest
lupus trial ever.

today 's lists
Latest Activist Situations

Here are the latest Activist or "13D" situations from the StreetInsider.com 13D Tracker page found at: http://www.13dtracker.blogspot.com/.... more

TheStreet.com TV Videos

These are some of the stocks mentioned today on TheStreet.com TV. Click the URL below each stock to watch the videos. more

Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more